Texas A&M Center Adds Mobile Cleanrooms - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Texas A&M Center Adds Mobile Cleanrooms



Walker Barrier Systems, a producer of isolation and containment equipment, has built and delivered the first of eight mobile clean rooms for the Texas A&M Center for Innovation in Advanced Development and Manufacturing (CIADM).

The Texas A&M Center for Innovation is home to the National Center for Therapeutics Manufacturing (NCTM), which provides a facility for the development and production of vaccines and therapeutics for use in clinical trials. The addition of eight new mobile clean rooms to theNCTM will increase the development and manufacturing capacity of the CIADM.

The Walker Barrier Systems mobile clean room design will allow the NCTM to manufacture clinical grade materials at increased levels of compliance. Walker Barrier Systems units are built to support a wide range of processes and platforms that will be required by CIADM to manufacture biosecurity medical countermeasures.

Construction of the mobile clean rooms began in May 2013, and all eight are expected to be in operation at the NCTM by early 2014. The first unit was delivered in January 2014.

Source: Walker Barrier Systems

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race

Click here